Awarded credibility Terumo Aortic has recently earned prestigious awards including King’s Award for Innovation and voluntary service, strengthening its credibility in innovation and social impact which can be leveraged in conversations with hospital procurement and regional distributors.

Breakthrough Device status FDA Breakthrough Device designation for Fenestrated TREO indicates strong regulatory progress and clinical value, presenting an opportunity to engage with U.S. customers on advanced device adoption timelines and potential reimbursement discussions.

European expansion Recent facility expansion in Glasgow and recognition as Europe’s company of the year signals growing capacity and regional service capabilities, enabling a sales approach focused on expanded supply, local clinical support, and faster delivery to European accounts.

Digital portfolio Strategic move to complement implantable devices with digital technologies creates upsell opportunities for digital health integration, remote monitoring, data analytics services, and enhanced post-market support with existing customers.

Comprehensive solutions Broad and customizable aortic care solutions position Terumo Aortic as a partner for hospitals seeking integrated suites—target multi-department buyers (surgery, radiology, vascular, IT) for bundled procurement and long-term contracting.